1999
DOI: 10.1006/excr.1999.4687
|View full text |Cite
|
Sign up to set email alerts
|

New Insights into the Control of MAP Kinase Pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
290
1
3

Year Published

2001
2001
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 390 publications
(305 citation statements)
references
References 191 publications
8
290
1
3
Order By: Relevance
“…MKP-1 is an endogenous inhibitor of the MAPK and is a dual-specificity phosphatase (Camps et al 2000;English et al 1999). As such, MKP-1 acts to inactivate the main members of the MAPK family such as ERK, P38, and JNK.…”
Section: Anxa1 Regulates Tnfα Mrna Stabilitymentioning
confidence: 99%
“…MKP-1 is an endogenous inhibitor of the MAPK and is a dual-specificity phosphatase (Camps et al 2000;English et al 1999). As such, MKP-1 acts to inactivate the main members of the MAPK family such as ERK, P38, and JNK.…”
Section: Anxa1 Regulates Tnfα Mrna Stabilitymentioning
confidence: 99%
“…There are three major sub-groups that include extracellular signal-regulated kinase (ERK1/2), p38 MAPK, and c-jun-N-terminal kinase (JNK). P38 MAPK is a subfamily of the stress-activated MAPKs (SAPKs) [40][41][42]. In isolated rat hearts, drugs like ketamine and imipramine have been shown to activate the MAPK/ERK (extracellular signal-regulated kinase), which is accompanied by an increase in Mg 2+ that results in decreased heart rate [18,43].…”
Section: Introductionmentioning
confidence: 99%
“…The mitogen-activated protein kinases (MAPK) transduce extracellular signals into cellular responses, and so they play important roles in proliferation, apoptosis, differentiation, migration and cytoskeleton remodeling of cells (English et al, 1999;Widmann et al, 1999).…”
Section: Introductionmentioning
confidence: 99%